Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jaime Bosch

Showing results (191-200 of 364) with videos related to

Pageof 37
Sort By:
Hepatology (Baltimore, Md.)|January 24, 2003
Low doses of isosorbide mononitrate attenuate the postprandial increase in portal pressure in patients with cirrhosisLia Bellis, Annalisa Berzigotti, Juan G Abraldes, et al.
The American Journal of Gastroenterology|November 14, 2012
Cardiovascular risk factors and systemic endothelial function in patients with cirrhosisAnnalisa Berzigotti, Eva Erice, Rosa Gilabert, et al.
Emerging Infectious Diseases|December 17, 2005
Chytrid fungus in EuropeTrenton W J Garner, Susan Walker, Jaime Bosch, et al.
Hepatology (Baltimore, Md.)|October 16, 2004
PTFE-covered stents improve TIPS patency in Budd-Chiari syndromeManuel Hernández-Guerra, Juan Turnes, Pablo Rubinstein, et al.
The American Journal of Gastroenterology|November 19, 2009
NCX-1000, a nitric oxide-releasing derivative of UDCA, does not decrease portal pressure in patients with cirrhosis: results of a randomized, double-blind, dose-escalating studyAnnalisa Berzigotti, Pau Bellot, Andrea De Gottardi, et al.
Gastroenterology|February 12, 2009
Simvastatin lowers portal pressure in patients with cirrhosis and portal hypertension: a randomized controlled trialJuan G Abraldes, Agustin Albillos, Rafael Bañares, et al.
Journal of Hepatology|March 2, 2011
Insulin resistance and liver microcirculation in a rat model of early NAFLDMarcos Pasarín, Juan G Abraldes, Aina Rodríguez-Vilarrupla, et al.
Hepatology (Baltimore, Md.)|January 7, 2014
Disruption of negative feedback loop between vasohibin-1 and vascular endothelial growth factor decreases portal pressure, angiogenesis, and fibrosis in cirrhotic ratsLaura Coch, Marc Mejias, Annalisa Berzigotti, et al.
Scientific Reports|February 10, 2024
Landscape connectivity for predicting the spread of ASF in the European wild boar populationTeresa Goicolea, Pablo Cisneros-Araújo, Cecilia Aguilar Vega, et al.
Hepatology (Baltimore, Md.)|December 24, 2005
Influence of beta-2 adrenergic receptor gene polymorphism on the hemodynamic response to propranolol in patients with cirrhosisJuan Turnes, Manuel Hernández-Guerra, Juan G Abraldes, et al.
Pageof 37

Showing results (191-200 of 364) with videos related to

Sort By:
Pageof 37
Hepatology (Baltimore, Md.)|January 24, 2003
Low doses of isosorbide mononitrate attenuate the postprandial increase in portal pressure in patients with cirrhosisLia Bellis, Annalisa Berzigotti, Juan G Abraldes, et al.
The American Journal of Gastroenterology|November 14, 2012
Cardiovascular risk factors and systemic endothelial function in patients with cirrhosisAnnalisa Berzigotti, Eva Erice, Rosa Gilabert, et al.
Emerging Infectious Diseases|December 17, 2005
Chytrid fungus in EuropeTrenton W J Garner, Susan Walker, Jaime Bosch, et al.
Hepatology (Baltimore, Md.)|October 16, 2004
PTFE-covered stents improve TIPS patency in Budd-Chiari syndromeManuel Hernández-Guerra, Juan Turnes, Pablo Rubinstein, et al.
The American Journal of Gastroenterology|November 19, 2009
NCX-1000, a nitric oxide-releasing derivative of UDCA, does not decrease portal pressure in patients with cirrhosis: results of a randomized, double-blind, dose-escalating studyAnnalisa Berzigotti, Pau Bellot, Andrea De Gottardi, et al.
Gastroenterology|February 12, 2009
Simvastatin lowers portal pressure in patients with cirrhosis and portal hypertension: a randomized controlled trialJuan G Abraldes, Agustin Albillos, Rafael Bañares, et al.
Journal of Hepatology|March 2, 2011
Insulin resistance and liver microcirculation in a rat model of early NAFLDMarcos Pasarín, Juan G Abraldes, Aina Rodríguez-Vilarrupla, et al.
Hepatology (Baltimore, Md.)|January 7, 2014
Disruption of negative feedback loop between vasohibin-1 and vascular endothelial growth factor decreases portal pressure, angiogenesis, and fibrosis in cirrhotic ratsLaura Coch, Marc Mejias, Annalisa Berzigotti, et al.
Scientific Reports|February 10, 2024
Landscape connectivity for predicting the spread of ASF in the European wild boar populationTeresa Goicolea, Pablo Cisneros-Araújo, Cecilia Aguilar Vega, et al.
Hepatology (Baltimore, Md.)|December 24, 2005
Influence of beta-2 adrenergic receptor gene polymorphism on the hemodynamic response to propranolol in patients with cirrhosisJuan Turnes, Manuel Hernández-Guerra, Juan G Abraldes, et al.
Pageof 37